
Iteos Therapeutics Inc (ITOS)
US$ 9.270.98%
Price Chart
Key Statistics
Market Cap
$ 445.69M
P/E Ratio
0.00
Revenue (TTM)
$ 35M
Volume
372.78K
52W High
$ 18.13
52W Low
$ 4.80
Dividend Yield
0.00%
Beta
1.49
Technicals
50-Day MA
9.9848
200-Day MA
8.1843
52 Week High
18.13
52 Week Low
4.8
About ITOS
iTeos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients with cancer.
Employees
173
Headquarters
Watertown, MA
CEO
Dr. Michel Detheux Ph.D.
Latest News
From a set and 4-1 down, Ito saves match point to stun Paolini in Montreal - WTA Tennis
3 days ago • Google News
Junji Ito’s ‘Uzumaki’ Anime Series Spirals Out on Blu-ray in September - Bloody Disgusting
19 hours ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg